25 XP   0   0   10

NanJing Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse NanJing Pharmaceutical Co Ltd together

PenkeI guess you are interested in NanJing Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of NanJing Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about NanJing Pharmaceutical Co Ltd

I send you an email if I find something interesting about NanJing Pharmaceutical Co Ltd.

Quick analysis of NanJing Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of NanJing Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.25
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥5.54
Expected worth in 1 year
¥7.25
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥3.51
Return On Investment
74.0%

For what price can you sell your share?

Current Price per Share
¥4.74
Expected price per share
¥4.4 - ¥4.76
How sure are you?
50%

1. Valuation of NanJing Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥4.74

Intrinsic Value Per Share

¥1.30 - ¥12.16

Total Value Per Share

¥6.83 - ¥17.70

2. Growth of NanJing Pharmaceutical Co Ltd (5 min.)




Is NanJing Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$1b$923.8m$77.2m7.7%

How much money is NanJing Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$79.7m$82.2m-$2.4m-3.1%
Net Profit Margin1.1%1.2%--

How much money comes from the company's main activities?

3. Financial Health of NanJing Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of NanJing Pharmaceutical Co Ltd? (5 min.)

Welcome investor! NanJing Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of NanJing Pharmaceutical Co Ltd.

What can you expect buying and holding a share of NanJing Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of NanJing Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of NanJing Pharmaceutical Co Ltd is ¥4.74. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of NanJing Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in NanJing Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥5.54. Based on the TTM, the Book Value Change Per Share is ¥0.43 per quarter. Based on the YOY, the Book Value Change Per Share is ¥1.11 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.45 per quarter.
Based on historical numbers we can estimate the returns while holding a share of NanJing Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.061.3%0.061.3%0.061.3%0.051.1%0.040.7%
Usd Book Value Change Per Share0.061.2%0.061.2%0.153.2%0.071.4%0.061.3%
Usd Dividend Per Share0.061.3%0.061.3%0.051.1%0.061.3%0.040.9%
Usd Total Gains Per Share0.122.6%0.122.6%0.204.3%0.132.7%0.112.2%
Usd Price Per Share0.67-0.67-0.71-0.66-0.83-
Price to Earnings Ratio10.97-10.97-11.26-13.63-34.26-
Price-to-Total Gains Ratio5.52-5.52-3.45-5.88-10.91-
Price to Book Ratio0.87-0.87-1.00-1.13-2.19-
Price-to-Total Gains Ratio5.52-5.52-3.45-5.88-10.91-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.65412
Number of shares1528
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.060.06
Usd Book Value Change Per Share0.060.07
Usd Total Gains Per Share0.120.13
Gains per Quarter (1528 shares)184.82193.29
Gains per Year (1528 shares)739.29773.16
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1378361729368405763
275772214687368101536
3113510822207110412152309
4151414432946147316203082
5189218043685184120253855
6227121654424220924304628
7264925265163257728355401
8302828865902294532406174
9340632476641331336456947
10378536087380368140507720

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%23.00.01.095.8%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%19.05.00.079.2%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%24.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%24.00.00.0100.0%

Fundamentals of NanJing Pharmaceutical Co Ltd

About NanJing Pharmaceutical Co Ltd

NanJing Pharmaceutical Company Limited engages in the pharmaceutical wholesale and retail businesses in China. It also operates various pharmacies and an e-commerce platform. The company was founded in 1951 and is based in Nanjing, China.

Fundamental data was last updated by Penke on 2024-04-17 09:47:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of NanJing Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit NanJing Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare NanJing Pharmaceutical Co Ltd to the Drug Manufacturers - General industry mean.
  • A Net Profit Margin of 1.1% means that ¥0.01 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of NanJing Pharmaceutical Co Ltd:

  • The MRQ is 1.1%. The company is making a profit. +1
  • The TTM is 1.1%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ1.1%TTM1.1%0.0%
TTM1.1%YOY1.2%-0.1%
TTM1.1%5Y1.1%+0.0%
5Y1.1%10Y0.9%+0.2%
1.1.2. Return on Assets

Shows how efficient NanJing Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare NanJing Pharmaceutical Co Ltd to the Drug Manufacturers - General industry mean.
  • 2.0% Return on Assets means that NanJing Pharmaceutical Co Ltd generated ¥0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of NanJing Pharmaceutical Co Ltd:

  • The MRQ is 2.0%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.0%TTM2.0%0.0%
TTM2.0%YOY1.9%+0.2%
TTM2.0%5Y1.8%+0.2%
5Y1.8%10Y1.6%+0.3%
1.1.3. Return on Equity

Shows how efficient NanJing Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare NanJing Pharmaceutical Co Ltd to the Drug Manufacturers - General industry mean.
  • 9.0% Return on Equity means NanJing Pharmaceutical Co Ltd generated ¥0.09 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of NanJing Pharmaceutical Co Ltd:

  • The MRQ is 9.0%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 9.0%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ9.0%TTM9.0%0.0%
TTM9.0%YOY9.9%-0.9%
TTM9.0%5Y9.5%-0.5%
5Y9.5%10Y8.3%+1.2%

1.2. Operating Efficiency of NanJing Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient NanJing Pharmaceutical Co Ltd is operating .

  • Measures how much profit NanJing Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare NanJing Pharmaceutical Co Ltd to the Drug Manufacturers - General industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of NanJing Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY2.8%-2.8%
TTM-5Y2.2%-2.2%
5Y2.2%10Y2.0%+0.2%
1.2.2. Operating Ratio

Measures how efficient NanJing Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • An Operation Ratio of 1.91 means that the operating costs are ¥1.91 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of NanJing Pharmaceutical Co Ltd:

  • The MRQ is 1.910. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.910. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.910TTM1.9100.000
TTM1.910YOY1.905+0.005
TTM1.9105Y1.907+0.003
5Y1.90710Y1.813+0.094

1.3. Liquidity of NanJing Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if NanJing Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A Current Ratio of 1.40 means the company has ¥1.40 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of NanJing Pharmaceutical Co Ltd:

  • The MRQ is 1.401. The company is just able to pay all its short-term debts.
  • The TTM is 1.401. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.401TTM1.4010.000
TTM1.401YOY1.313+0.088
TTM1.4015Y1.287+0.114
5Y1.28710Y1.108+0.180
1.3.2. Quick Ratio

Measures if NanJing Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare NanJing Pharmaceutical Co Ltd to the Drug Manufacturers - General industry mean.
  • A Quick Ratio of 0.63 means the company can pay off ¥0.63 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of NanJing Pharmaceutical Co Ltd:

  • The MRQ is 0.632. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.632. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.632TTM0.6320.000
TTM0.632YOY0.643-0.011
TTM0.6325Y0.633-0.001
5Y0.63310Y0.680-0.047

1.4. Solvency of NanJing Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of NanJing Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare NanJing Pharmaceutical Co Ltd to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.74 means that NanJing Pharmaceutical Co Ltd assets are financed with 74.5% credit (debt) and the remaining percentage (100% - 74.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of NanJing Pharmaceutical Co Ltd:

  • The MRQ is 0.745. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.745. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.745TTM0.7450.000
TTM0.745YOY0.788-0.044
TTM0.7455Y0.784-0.039
5Y0.78410Y0.786-0.002
1.4.2. Debt to Equity Ratio

Measures if NanJing Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare NanJing Pharmaceutical Co Ltd to the Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 328.7% means that company has ¥3.29 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of NanJing Pharmaceutical Co Ltd:

  • The MRQ is 3.287. The company is unable to pay all its debts with equity. -1
  • The TTM is 3.287. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ3.287TTM3.2870.000
TTM3.287YOY4.159-0.872
TTM3.2875Y4.129-0.841
5Y4.12910Y4.206-0.077

2. Market Valuation of NanJing Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings NanJing Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare NanJing Pharmaceutical Co Ltd to the Drug Manufacturers - General industry mean.
  • A PE ratio of 10.97 means the investor is paying ¥10.97 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of NanJing Pharmaceutical Co Ltd:

  • The EOD is 10.748. Based on the earnings, the company is underpriced. +1
  • The MRQ is 10.975. Based on the earnings, the company is underpriced. +1
  • The TTM is 10.975. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD10.748MRQ10.975-0.227
MRQ10.975TTM10.9750.000
TTM10.975YOY11.263-0.288
TTM10.9755Y13.627-2.653
5Y13.62710Y34.264-20.637
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of NanJing Pharmaceutical Co Ltd:

  • The EOD is 3.553. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 3.627. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 3.627. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD3.553MRQ3.627-0.075
MRQ3.627TTM3.6270.000
TTM3.627YOY-8.010+11.637
TTM3.6275Y3.344+0.284
5Y3.34410Y-19.850+23.194
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of NanJing Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 0.87 means the investor is paying ¥0.87 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of NanJing Pharmaceutical Co Ltd:

  • The EOD is 0.856. Based on the equity, the company is cheap. +2
  • The MRQ is 0.874. Based on the equity, the company is cheap. +2
  • The TTM is 0.874. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.856MRQ0.874-0.018
MRQ0.874TTM0.8740.000
TTM0.874YOY1.002-0.128
TTM0.8745Y1.134-0.260
5Y1.13410Y2.195-1.060
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of NanJing Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.4280.4280%1.115-62%0.480-11%0.455-6%
Book Value Per Share--5.5375.5370%5.109+8%4.354+27%3.359+65%
Current Ratio--1.4011.4010%1.313+7%1.287+9%1.108+26%
Debt To Asset Ratio--0.7450.7450%0.788-6%0.784-5%0.786-5%
Debt To Equity Ratio--3.2873.2870%4.159-21%4.129-20%4.206-22%
Dividend Per Share--0.4490.4490%0.369+22%0.436+3%0.317+41%
Eps--0.4410.4410%0.455-3%0.367+20%0.257+72%
Free Cash Flow Per Share--1.3341.3340%-0.639+148%0.092+1349%-0.088+107%
Free Cash Flow To Equity Per Share--1.3341.3340%-0.283+121%0.136+883%0.132+911%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--12.159--------
Intrinsic Value_10Y_min--1.296--------
Intrinsic Value_1Y_max--0.523--------
Intrinsic Value_1Y_min---0.033--------
Intrinsic Value_3Y_max--2.102--------
Intrinsic Value_3Y_min--0.041--------
Intrinsic Value_5Y_max--4.319--------
Intrinsic Value_5Y_min--0.268--------
Market Cap6210490275.840-2%6341518098.0806341518098.0800%6708812861.440-5%6289192076.832+1%7871905936.144-19%
Net Profit Margin--0.0110.0110%0.012-9%0.011+2%0.009+22%
Operating Margin----0%0.028-100%0.022-100%0.020-100%
Operating Ratio--1.9101.9100%1.905+0%1.907+0%1.813+5%
Pb Ratio0.856-2%0.8740.8740%1.002-13%1.134-23%2.195-60%
Pe Ratio10.748-2%10.97510.9750%11.263-3%13.627-19%34.264-68%
Price Per Share4.740-2%4.8404.8400%5.120-5%4.800+1%6.008-19%
Price To Free Cash Flow Ratio3.553-2%3.6273.6270%-8.010+321%3.344+8%-19.850+647%
Price To Total Gains Ratio5.408-2%5.5225.5220%3.452+60%5.880-6%10.910-49%
Quick Ratio--0.6320.6320%0.643-2%0.6330%0.680-7%
Return On Assets--0.0200.0200%0.019+8%0.018+12%0.016+31%
Return On Equity--0.0900.0900%0.099-10%0.095-5%0.083+8%
Total Gains Per Share--0.8760.8760%1.483-41%0.917-4%0.773+13%
Usd Book Value--1001179835.0181001179835.0180%923894278.685+8%787253896.233+27%607373732.149+65%
Usd Book Value Change Per Share--0.0590.0590%0.154-62%0.066-11%0.063-6%
Usd Book Value Per Share--0.7640.7640%0.705+8%0.601+27%0.464+65%
Usd Dividend Per Share--0.0620.0620%0.051+22%0.060+3%0.044+41%
Usd Eps--0.0610.0610%0.063-3%0.051+20%0.035+72%
Usd Free Cash Flow--241250022.736241250022.7360%-115587480.416+148%16648151.260+1349%-14314262.735+106%
Usd Free Cash Flow Per Share--0.1840.1840%-0.088+148%0.013+1349%-0.012+107%
Usd Free Cash Flow To Equity Per Share--0.1840.1840%-0.039+121%0.019+883%0.018+911%
Usd Market Cap857047658.066-2%875129497.535875129497.5350%925816174.879-5%867908506.603+1%1086323019.188-19%
Usd Price Per Share0.654-2%0.6680.6680%0.707-5%0.662+1%0.829-19%
Usd Profit--79739939.47879739939.4780%82202156.814-3%66295463.174+20%46526025.196+71%
Usd Revenue--7395373732.4927395373732.4920%6930575806.198+7%6235047817.400+19%4943655269.980+50%
Usd Total Gains Per Share--0.1210.1210%0.205-41%0.126-4%0.107+13%
 EOD+4 -4MRQTTM+0 -0YOY+19 -165Y+24 -1110Y+25 -10

3.2. Fundamental Score

Let's check the fundamental score of NanJing Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1510.748
Price to Book Ratio (EOD)Between0-10.856
Net Profit Margin (MRQ)Greater than00.011
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.632
Current Ratio (MRQ)Greater than11.401
Debt to Asset Ratio (MRQ)Less than10.745
Debt to Equity Ratio (MRQ)Less than13.287
Return on Equity (MRQ)Greater than0.150.090
Return on Assets (MRQ)Greater than0.050.020
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of NanJing Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5059.575
Ma 20Greater thanMa 504.646
Ma 50Greater thanMa 1004.547
Ma 100Greater thanMa 2004.677
OpenGreater thanClose4.710
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets28,410,232
Total Liabilities21,155,305
Total Stockholder Equity6,435,194
 As reported
Total Liabilities 21,155,305
Total Stockholder Equity+ 6,435,194
Total Assets = 28,410,232

Assets

Total Assets28,410,232
Total Current Assets26,012,897
Long-term Assets2,397,335
Total Current Assets
Cash And Cash Equivalents 2,371,579
Net Receivables 11,741,006
Inventory 5,798,006
Other Current Assets 152,950
Total Current Assets  (as reported)26,012,897
Total Current Assets  (calculated)20,063,542
+/- 5,949,355
Long-term Assets
Property Plant Equipment 1,506,808
Goodwill 72,167
Intangible Assets 218,976
Long-term Assets Other 4,245
Long-term Assets  (as reported)2,397,335
Long-term Assets  (calculated)1,802,196
+/- 595,139

Liabilities & Shareholders' Equity

Total Current Liabilities18,566,034
Long-term Liabilities2,589,272
Total Stockholder Equity6,435,194
Total Current Liabilities
Short Long Term Debt 1,763,671
Accounts payable 9,693,581
Other Current Liabilities 2,173,337
Total Current Liabilities  (as reported)18,566,034
Total Current Liabilities  (calculated)13,630,589
+/- 4,935,445
Long-term Liabilities
Long term Debt 2,117,777
Capital Lease Obligations Min Short Term Debt119,022
Long-term Liabilities  (as reported)2,589,272
Long-term Liabilities  (calculated)2,236,799
+/- 352,473
Total Stockholder Equity
Retained Earnings 2,332,990
Total Stockholder Equity (as reported)6,435,194
Total Stockholder Equity (calculated)2,332,990
+/- 4,102,205
Other
Capital Stock1,310,231
Common Stock Shares Outstanding 1,310,231
Net Debt 1,509,869
Net Invested Capital 10,316,642
Net Working Capital 7,446,863
Property Plant and Equipment Gross 1,506,808



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
> Total Assets 
1,229,238
1,169,969
1,816,297
2,629,994
3,134,129
3,328,739
3,687,228
4,999,293
5,043,950
6,517,671
8,373,920
9,024,539
9,227,049
9,649,666
11,362,292
12,594,788
13,961,834
15,925,206
19,554,816
21,965,560
23,409,572
25,885,712
31,650,960
28,410,232
28,410,23231,650,96025,885,71223,409,57221,965,56019,554,81615,925,20613,961,83412,594,78811,362,2929,649,6669,227,0499,024,5398,373,9206,517,6715,043,9504,999,2933,687,2283,328,7393,134,1292,629,9941,816,2971,169,9691,229,238
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,292,584
12,427,201
14,948,680
17,700,793
19,747,772
21,164,734
23,457,942
29,261,483
26,012,897
26,012,89729,261,48323,457,94221,164,73419,747,77217,700,79314,948,68012,427,20111,292,584000000000000000
       Cash And Cash Equivalents 
118,227
89,954
179,002
287,011
363,875
535,341
688,433
1,002,041
947,689
1,269,088
1,980,899
1,620,489
1,938,214
1,456,543
1,907,380
1,278,081
1,209,874
1,774,083
2,265,008
2,103,416
1,478,749
2,093,321
2,327,196
2,371,579
2,371,5792,327,1962,093,3211,478,7492,103,4162,265,0081,774,0831,209,8741,278,0811,907,3801,456,5431,938,2141,620,4891,980,8991,269,088947,6891,002,041688,433535,341363,875287,011179,00289,954118,227
       Short-term Investments 
47,618
187
33,893
34,021
2,752
1,486
386
2,162
0
0
13,420
11,991
12,432
0
0
0
0
0
0
0
0
0
0
0
0000000000012,43211,99113,420002,1623861,4862,75234,02133,89318747,618
       Net Receivables 
286,380
313,516
510,318
943,963
1,204,038
1,182,352
1,378,253
1,913,589
1,975,897
2,308,348
3,121,174
4,160,320
3,998,244
4,740,958
5,974,344
7,328,309
7,468,233
9,406,592
11,677,031
12,759,465
9,077,516
10,809,872
14,330,528
11,741,006
11,741,00614,330,52810,809,8729,077,51612,759,46511,677,0319,406,5927,468,2337,328,3095,974,3444,740,9583,998,2444,160,3203,121,1742,308,3481,975,8971,913,5891,378,2531,182,3521,204,038943,963510,318313,516286,380
       Other Current Assets 
27,130
28,813
44,290
65,749
151,838
189,796
189,727
274,326
362,114
549,130
673,125
472,026
528,616
544,034
505,120
601,389
1,176,683
856,142
816,899
1,167,299
1,327,789
1,570,975
1,812,515
152,950
152,9501,812,5151,570,9751,327,7891,167,299816,899856,1421,176,683601,389505,120544,034528,616472,026673,125549,130362,114274,326189,727189,796151,83865,74944,29028,81327,130
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,534,633
1,588,872
1,854,023
2,217,788
2,244,838
2,427,770
2,389,477
2,397,335
2,397,3352,389,4772,427,7702,244,8382,217,7881,854,0231,588,8721,534,6330000000000000000
       Property Plant Equipment 
398,303
382,652
410,049
529,676
542,781
652,991
630,678
709,264
673,430
946,966
1,054,023
928,461
985,351
953,226
620,698
650,604
807,407
888,745
1,094,013
1,177,998
1,186,769
1,492,048
1,519,069
1,506,808
1,506,8081,519,0691,492,0481,186,7691,177,9981,094,013888,745807,407650,604620,698953,226985,351928,4611,054,023946,966673,430709,264630,678652,991542,781529,676410,049382,652398,303
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,368
3,073
2,382
2,382
13,525
74,167
74,167
72,167
72,167
72,167
72,16772,16772,16774,16774,16713,5252,3822,3823,0733,36800000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
153,630
242,936
205,912
231,677
0
0
0
0
0
00000231,677205,912242,936153,630000000000000000
       Intangible Assets 
14,358
16,297
53,595
91,307
116,590
16,583
15,520
13,422
11,331
32,740
16,580
33,598
51,855
38,657
197,254
180,182
190,366
190,921
191,644
255,446
282,168
268,112
245,284
218,976
218,976245,284268,112282,168255,446191,644190,921190,366180,182197,25438,65751,85533,59816,58032,74011,33113,42215,52016,583116,59091,30753,59516,29714,358
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,534,633
1,588,872
1,854,023
11,034
32,350
36,849
2,050
4,245
4,2452,05036,84932,35011,0341,854,0231,588,8721,534,6330000000000000000
> Total Liabilities 
742,308
697,925
1,311,005
2,018,159
2,519,991
2,681,804
3,043,260
4,298,367
4,433,260
5,772,896
7,110,014
7,666,411
7,913,360
8,361,623
8,924,967
9,908,200
10,892,509
12,738,684
15,445,679
17,445,574
18,589,442
20,651,949
24,956,074
21,155,305
21,155,30524,956,07420,651,94918,589,44217,445,57415,445,67912,738,68410,892,5099,908,2008,924,9678,361,6237,913,3607,666,4117,110,0145,772,8964,433,2604,298,3673,043,2602,681,8042,519,9912,018,1591,311,005697,925742,308
   > Total Current Liabilities 
714,940
696,208
1,302,551
2,012,760
2,516,533
2,671,522
2,925,930
4,180,395
4,291,622
5,676,284
6,970,684
7,586,935
7,637,625
8,134,463
8,676,222
9,702,517
10,717,147
13,011,478
15,143,121
17,122,313
17,202,514
17,524,640
22,283,780
18,566,034
18,566,03422,283,78017,524,64017,202,51417,122,31315,143,12113,011,47810,717,1479,702,5178,676,2228,134,4637,637,6257,586,9356,970,6845,676,2844,291,6224,180,3952,925,9302,671,5222,516,5332,012,7601,302,551696,208714,940
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,769,000
5,052,000
3,035,100
3,160,000
0
0
0
0
00003,160,0003,035,1005,052,0001,769,0000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,769,000
5,052,000
3,035,100
3,160,000
5,110,000
3,668,851
1,804,552
1,763,671
1,763,6711,804,5523,668,8515,110,0003,160,0003,035,1005,052,0001,769,0000000000000000000
       Accounts payable 
240,746
296,593
576,775
925,917
1,319,279
1,467,041
1,748,781
2,644,905
2,469,922
3,213,689
4,361,371
4,309,193
4,353,743
3,690,092
4,623,551
4,686,643
5,130,463
5,986,216
6,550,046
7,592,856
7,633,677
8,064,121
10,130,916
9,693,581
9,693,58110,130,9168,064,1217,633,6777,592,8566,550,0465,986,2165,130,4634,686,6434,623,5513,690,0924,353,7434,309,1934,361,3713,213,6892,469,9222,644,9051,748,7811,467,0411,319,279925,917576,775296,593240,746
       Other Current Liabilities 
147,323
113,640
275,226
268,593
272,864
281,591
269,459
446,267
477,888
607,470
430,836
709,095
1,095,383
1,166,526
512,633
421,776
608,172
1,032,444
1,255,493
1,206,208
1,610,552
1,966,943
4,770,108
2,173,337
2,173,3374,770,1081,966,9431,610,5521,206,2081,255,4931,032,444608,172421,776512,6331,166,5261,095,383709,095430,836607,470477,888446,267269,459281,591272,864268,593275,226113,640147,323
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
175,361
230,299
302,558
323,261
1,386,928
3,127,308
2,672,293
2,589,272
2,589,2722,672,2933,127,3081,386,928323,261302,558230,299175,3610000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1,769,000
-5,052,000
-3,035,100
-3,160,000
180,662
124,397
103,233
119,022
119,022103,233124,397180,662-3,160,000-3,035,100-5,052,000-1,769,0000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
133,075
117,107
104,687
100,745
50,531
52,762
34,245
36,892
0
036,89234,24552,76250,531100,745104,687117,107133,075000000000000000
> Total Stockholder Equity
456,513
434,434
436,905
465,230
452,863
469,279
464,929
504,595
483,851
555,299
1,002,982
939,301
999,110
1,014,670
2,141,221
2,301,165
2,626,181
2,777,721
3,669,168
4,013,573
4,257,543
4,606,309
5,999,859
6,435,194
6,435,1945,999,8594,606,3094,257,5434,013,5733,669,1682,777,7212,626,1812,301,1652,141,2211,014,670999,110939,3011,002,982555,299483,851504,595464,929469,279452,863465,230436,905434,434456,513
   Common Stock
194,261
194,261
194,261
194,261
194,261
194,261
250,767
250,767
250,767
300,920
346,790
693,581
693,581
693,581
897,426
897,426
897,426
897,426
1,041,611
1,041,611
1,041,611
1,041,611
0
0
001,041,6111,041,6111,041,6111,041,611897,426897,426897,426897,426693,581693,581693,581346,790300,920250,767250,767250,767194,261194,261194,261194,261194,261194,261
   Retained Earnings 
10,447
10,987
6,250
20,225
9,437
22,493
25,273
71,624
77,877
97,360
108,574
0
0
0
159,278
316,002
478,326
692,750
863,299
1,112,545
1,387,725
1,778,330
1,979,703
2,332,990
2,332,9901,979,7031,778,3301,387,7251,112,545863,299692,750478,326316,002159,278000108,57497,36077,87771,62425,27322,4939,43720,2256,25010,98710,447
   Capital Surplus 000000000000000000000000
   Treasury Stock000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,351
78,603
79,157
102,931
197,593
176,603
406,602
369,186
0
0369,186406,602176,603197,593102,93179,15778,6032,351000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue53,589,665
Cost of Revenue-50,276,362
Gross Profit3,313,3033,313,303
 
Operating Income (+$)
Gross Profit3,313,303
Operating Expense-52,071,293
Operating Income1,518,372-48,757,990
 
Operating Expense (+$)
Research Development36,189
Selling General Administrative1,255,450
Selling And Marketing Expenses0
Operating Expense52,071,2931,291,639
 
Net Interest Income (+$)
Interest Income10,135
Interest Expense-378,494
Other Finance Cost-166,393
Net Interest Income-534,751
 
Pretax Income (+$)
Operating Income1,518,372
Net Interest Income-534,751
Other Non-Operating Income Expenses0
Income Before Tax (EBT)978,0681,518,372
EBIT - interestExpense = -378,494
577,826
956,319
Interest Expense378,494
Earnings Before Interest and Taxes (EBIT)01,356,562
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax978,068
Tax Provision-265,259
Net Income From Continuing Ops712,809712,809
Net Income577,826
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0534,751
 

Technical Analysis of NanJing Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of NanJing Pharmaceutical Co Ltd. The general trend of NanJing Pharmaceutical Co Ltd is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine NanJing Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of NanJing Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 4.71 < 4.76 < 4.76.

The bearish price targets are: 4.45 > 4.43 > 4.4.

Tweet this
NanJing Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of NanJing Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

NanJing Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of NanJing Pharmaceutical Co Ltd. The current macd is 0.04304827.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the NanJing Pharmaceutical Co Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for NanJing Pharmaceutical Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the NanJing Pharmaceutical Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
NanJing Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartNanJing Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of NanJing Pharmaceutical Co Ltd. The current adx is 15.51.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy NanJing Pharmaceutical Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
NanJing Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of NanJing Pharmaceutical Co Ltd. The current sar is 4.47644303.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
NanJing Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of NanJing Pharmaceutical Co Ltd. The current rsi is 59.58. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
NanJing Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartNanJing Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of NanJing Pharmaceutical Co Ltd. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the NanJing Pharmaceutical Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
NanJing Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartNanJing Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of NanJing Pharmaceutical Co Ltd. The current cci is 105.26.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
NanJing Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartNanJing Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of NanJing Pharmaceutical Co Ltd. The current cmo is 25.61.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
NanJing Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartNanJing Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of NanJing Pharmaceutical Co Ltd. The current willr is -6.4516129.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
NanJing Pharmaceutical Co Ltd Daily Williams %R ChartNanJing Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of NanJing Pharmaceutical Co Ltd.

NanJing Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of NanJing Pharmaceutical Co Ltd. The current atr is 0.09614081.

NanJing Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartNanJing Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of NanJing Pharmaceutical Co Ltd. The current obv is 857,946,791.

NanJing Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartNanJing Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of NanJing Pharmaceutical Co Ltd. The current mfi is 62.64.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
NanJing Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartNanJing Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for NanJing Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-18BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside

6.3. Candlestick Patterns

NanJing Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of NanJing Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5059.575
Ma 20Greater thanMa 504.646
Ma 50Greater thanMa 1004.547
Ma 100Greater thanMa 2004.677
OpenGreater thanClose4.710
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of NanJing Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on NanJing Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about NanJing Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about NanJing Pharmaceutical Co Ltd

I send you an email if I find something interesting about NanJing Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about NanJing Pharmaceutical Co Ltd.

Receive notifications about NanJing Pharmaceutical Co Ltd in your mailbox!